Licensed marijuana producer Aphria Inc. (TSX:APH) said it is moving to “purify” its balance sheet by reducing its exposure to medical cannabis in the U.S., where pot remains illegal under federal law, as it undergoes a delisting review by the group which operates the Toronto Stock Exchange. Aphria’s … Read More
The post Aphria to cut down US cannabis exposure amid TSX delisting review appeared first on Dagga Magazine.